A two-fold ambition for Evolucare: international expansion and Artificial Intelligence. Supported by its new partner, Essling Expansion, Evolucare targets a robust growth both internally and externally. The company is relying on Artificial Intelligence, for instance with its new product OphtAI for the detection of diabetic retinopathy, and international expansion to reach its ambitions.
While the healthcare sector is rapidly evolving towards new models and novel practices—geared towards both digitisation and integrated care—Evolucare expands its range of solutions by acquiring Axapa, the specialist in software solutions in the social care sector, and in particular for disable people care.
We are committed to adding value to our core business – patient data management and healthcare organisation – by adding decision support services using our expert algorithms to our range of services.